Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL135748 | 0.89 | LMNA (0.31) | — | |
| Sulfuric Acid SCHEMBL27603434 | 0.80 | KDM4E (0.42) | CA1CA2CA9CA12KDM4E | |
| Sulfuric Acid SCHEMBL27576948 | 0.76 | POLB (0.46) | CA1CA2CA9CA12KDM4E | |
| SCHEMBL4264509 | 0.75 | HTT (0.38) | KDM4E | |
| Sulfuric Acid SCHEMBL3344978 | 0.75 | CA5A (0.43) | CA1CA2CA9CA12KDM4E | |
| Sulfuric Acid SCHEMBL129071 | 0.75 | CA5A (0.43) | CA1CA2CA9CA12KDM4E | |
| Sulfuric Acid SCHEMBL30393314 | 0.75 | CA5A (0.43) | CA1CA2CA9CA12KDM4E | |
| Sulfuric Acid SCHEMBL3338642 | 0.75 | CA5A (0.43) | CA1CA2CA9CA12KDM4E | |
| Sulfuric Acid SCHEMBL28225280 | 0.72 | CA5A (0.40) | CA1CA2CA9CA12KDM4E | |
| Sulfuric Acid SCHEMBL11529048 | 0.72 | CA5A (0.40) | CA1CA2CA9CA12KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4685172-A1 | CURABLE COMPOUND, CURABLE RESIN COMPOSITION, CURED ARTICLE AND LAMINATE | DIC Corporation (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-4685185-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, LAMINATE, AND CURABLE COMPOUND | DIC Corporation (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-4685171-A1 | CURABLE COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC Corporation (JP) | 2026-01-28 | — | — | EP | disclosed |
| US-12468104-B2 | Optical cable | SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) | 2025-11-11 | — | — | US | disclosed |
| US-20250320180-A1 | HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT | DIC CORPORATION (JP) | 2025-10-16 | — | — | US | disclosed |
| US-20250277081-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED OBJECT, AND LAMINATE | DIC CORPORATION (JP) | 2025-09-04 | — | — | US | disclosed |
| US-20250277080-A1 | PHENOLIC HYDROXY GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC CORPORATION (JP) | 2025-09-04 | — | — | US | disclosed |
| EP-4592327-A1 | CURABLE COMPOSITION AND SYNTHETIC LEATHER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-07-30 | — | — | EP | disclosed |
| EP-4585594-A1 | GLYCIDYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT AND MULTILAYER BODY | DIC Corporation (JP) | 2025-07-16 | — | — | EP | disclosed |
| US-20250223396-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC CORPORATION (JP) | 2025-07-10 | — | — | US | disclosed |
| US-20040266916-A1 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2004-12-30 | — | — | US | disclosed |
| US-20040254270-A1 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1486536-A1 | FLAME-RETARDANT RESIN COMPOSITION | Polyplastics Co Ltd (JP) | 2004-12-15 | — | — | EP | disclosed |
| EP-1466946-A1 | FLAME-RETARDANT RESIN COMPOSITION | Polyplastics Co., Ltd. (JP) | 2004-10-13 | — | — | EP | disclosed |
| EP-1452567-A1 | FLAME-RETARDANT RESIN COMPOSITION | Polyplastics Co Ltd (JP) | 2004-09-01 | — | — | EP | disclosed |
| US-20040063815-A1 | Modified red phosphorus, method of producing the same, decolorized red phosphorus composition and flame-retardant polymer composition | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1116773-B1 | FLAME RETARDANT COMPOSITION AND FLAME-RETARDANT RESIN COMPOSITION | NIPPON CHEMICAL IND COMPANY LT (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-20030197159-A1 | Red phosphorus overcoated with thermosetting resins | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2003-10-23 | — | — | US | disclosed |
| EP-1116772-A1 | FLAME RETARDANT COMPOSITION AND FLAME-RETARDANT RESIN COMPOSITION | NIPPON CHEMICAL INDUSTRIAL COMPANY LIMITED (JP) | 2001-07-18 | — | — | EP | disclosed |
| EP-1116773-A1 | FLAME RETARDANT COMPOSITION AND FLAME-RETARDANT RESIN COMPOSITION | NIPPON CHEMICAL INDUSTRIAL COMPANY LIMITED (JP) | 2001-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320180-A1 | HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT | RAD51, SEM1, GFER | CA1 725/4885CA2 3282/4885CA9 2423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.